eskynet
05-29
$Tempus AI(TEM)$  give it a try , once risk management is taken care of.
TEM Rebounds on "Xm" News: Can Stock Return to $70?
Tempus AI surged over 8% intraday against the market trend after the company launched Xm, a test designed to monitor immunotherapy responses in patients with advanced cancer. TEM's stock price fell 20% last week after being targeted by a short report from Spruce Point. The report raised serious concerns about the integrity of Tempus AI's products, the credibility of its management team, and its financial reporting practices. ------- How do you view the rally after the short report? Did you buy the dip last week? Will you sell to take profit now or hold?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
2